AT363492B - Verfahren zur herstellung von cyclodextrin-einschlusskomplexen des allicins - Google Patents

Verfahren zur herstellung von cyclodextrin-einschlusskomplexen des allicins

Info

Publication number
AT363492B
AT363492B AT0782979A AT782979A AT363492B AT 363492 B AT363492 B AT 363492B AT 0782979 A AT0782979 A AT 0782979A AT 782979 A AT782979 A AT 782979A AT 363492 B AT363492 B AT 363492B
Authority
AT
Austria
Prior art keywords
allicin
including complexes
producing cyclodextrin
cyclodextrin including
producing
Prior art date
Application number
AT0782979A
Other languages
German (de)
English (en)
Other versions
ATA782979A (de
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of ATA782979A publication Critical patent/ATA782979A/de
Application granted granted Critical
Publication of AT363492B publication Critical patent/AT363492B/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Emergency Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT0782979A 1978-12-12 1979-12-12 Verfahren zur herstellung von cyclodextrin-einschlusskomplexen des allicins AT363492B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU78CI1871A HU177081B (en) 1978-12-12 1978-12-12 Process for preparing the occlusion complex of allicin with cyclodextrin

Publications (2)

Publication Number Publication Date
ATA782979A ATA782979A (de) 1981-01-15
AT363492B true AT363492B (de) 1981-08-10

Family

ID=10994715

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0782979A AT363492B (de) 1978-12-12 1979-12-12 Verfahren zur herstellung von cyclodextrin-einschlusskomplexen des allicins

Country Status (11)

Country Link
JP (1) JPS55115866A (zh)
AT (1) AT363492B (zh)
CH (1) CH642347A5 (zh)
DE (1) DE2948869A1 (zh)
DK (1) DK526779A (zh)
FR (1) FR2444060A1 (zh)
GB (1) GB2061987B (zh)
HU (1) HU177081B (zh)
NO (1) NO794044L (zh)
SU (1) SU938732A3 (zh)
YU (1) YU299079A (zh)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU184066B (en) 1979-12-28 1984-06-28 Chinoin Gyogyszer Es Vegyeszet Plant growth regulating substance and process for preparing such compound
JPS5920230A (ja) * 1982-07-19 1984-02-01 チバ−ガイギ−・アクチエンゲゼルシヤフト ピルプロフエン含有薬剤
FR2550193A1 (fr) * 1983-08-05 1985-02-08 Sal Fine Chemicals Internation Complexes d'inclusion de trisulfure de methyle et d'allyle avec des cyclodextrines, leur procede de preparation et compositions pharmaceutiques les contenant
HU196230B (en) * 1983-12-29 1988-10-28 Chinoin Gyogyszer Es Vegyeszet Process for producing water-soluble forms of polyene antibiotics and pharmaceutics comprising such active ingredient and plant protective with antifungal effect
EP0211392B1 (en) * 1985-08-06 1991-03-27 Kao Corporation Liquid shampoo composition
DE3638290A1 (de) * 1986-11-07 1988-05-19 Herbe Wirkstoffe Gmbh Arzneimittelzubereitung
US4774329A (en) * 1987-08-04 1988-09-27 American Maize-Products Company Controlled release agent for cetylpyridinium chloride
ATE124422T1 (de) * 1989-04-12 1995-07-15 Procter & Gamble Festes verbraucherprodukt, welches feinteilige cyclodextrin-komplexe enthält.
SE8902235D0 (sv) * 1989-06-20 1989-06-20 Haessle Ab Novel cyclodextrin inclusion complexes
CA2013485C (en) * 1990-03-06 1997-04-22 John Michael Gardlik Solid consumer product compositions containing small particle cyclodextrin complexes
DE4024155C2 (de) * 1990-07-30 1995-12-07 Marcela Dipl Ing Holzhey Verwendung eines "Allicin-Urotropin" Produktes für den Bereich der inneren Behandlung (oral, Injektionen und Dauertropfinfusionen) von Menschen und Tieren bei Pilzerkrankungen
DE4338508A1 (de) * 1993-11-11 1995-05-18 Asta Medica Ag Arzneimittelzubereitungen enthaltend Thioctsäure oder Dihydroliponsäure in Form von Einschlußverbindungen mit Cyclodextrinen oder Cyclodextrinderivaten und in Form von Granulaten, Kau- oder Brausetabletten
DE19500863A1 (de) * 1995-01-13 1996-07-18 Consortium Elektrochem Ind Verfahren zur Herstellung von Ajoen
GB0120887D0 (en) * 2001-08-29 2001-10-17 Sahajanand Biotech Private Ltd Local drug delivery system in coronary stents
GB0122793D0 (en) * 2001-09-21 2001-11-14 Stone Island Holdings Ltd Allicin
EP1721534A1 (en) * 2004-03-03 2006-11-15 Mousala, S. L. Use of extracts and compounds of allium-genus plants as preservatives in the food and agri-food industries
GB0422582D0 (en) * 2004-10-11 2004-11-10 Nasaleze Patents Ltd Pharmaceutical compositions
CN107802842B (zh) * 2016-09-07 2022-04-12 汤臣倍健股份有限公司 大蒜素矫味制剂及其制备方法
CN107789345B (zh) * 2016-09-07 2022-06-28 汤臣倍健股份有限公司 矫味大蒜素-环糊精复合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3061444A (en) * 1960-10-07 1962-10-30 Gen Foods Corp Inclusion compounds incorporating edible juice constituents
HU174699B (hu) * 1977-07-01 1980-03-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija natural'nykh i sinteticheskikh ciklodektrinnykh okkluzionnykh kompleksov prjaznostej, aromatov i vkusnykh vehhestv

Also Published As

Publication number Publication date
DK526779A (da) 1980-06-13
CH642347A5 (de) 1984-04-13
FR2444060A1 (fr) 1980-07-11
YU299079A (en) 1983-06-30
JPS642105B2 (zh) 1989-01-13
NO794044L (no) 1980-06-13
SU938732A3 (ru) 1982-06-23
GB2061987B (en) 1983-05-18
FR2444060B1 (zh) 1984-06-29
JPS55115866A (en) 1980-09-06
ATA782979A (de) 1981-01-15
DE2948869C2 (zh) 1992-07-09
DE2948869A1 (de) 1980-07-03
HU177081B (en) 1981-07-28
GB2061987A (en) 1981-05-20

Similar Documents

Publication Publication Date Title
AT363492B (de) Verfahren zur herstellung von cyclodextrin-einschlusskomplexen des allicins
AT370086B (de) Verfahren zur herstellung des d-camphorats von l-carnitinamid
AT363176B (de) Verfahren zur herstellung von cyclodextrin-kamillen-inklusionskomplexen
AT371097B (de) Verfahren zur herstellung von o-methallyloxyphenol
ATE125T1 (de) Verfahren zur herstellung von n-azolylmethyl-substituierten halogenacetaniliden.
AT384229B (de) Verfahren zur herstellung von viskosen
DD138197A1 (de) Verfahren zur herstellung von zement
AT369728B (de) Verfahren zur herstellung von trichloraethylen
DD134769A1 (de) Verfahren zur herstellung von 3-oxo-oestra-4,9,11-trienen
AT368508B (de) Verfahren zur herstellung von 3-carbamoyloxymethylcephalosporinverbindungen
AT367017B (de) Verfahren zur herstellung von p-amino-diphenylamin
ATE2618T1 (de) Verfahren zur herstellung von 2-isopropylaminopyrimidin.
DD137720A1 (de) Verfahren zur herstellung von alkylalkoxypolysiloxanen
AT373244B (de) Verfahren zur herstellung von n-tritylimidazolverbindungen
AT370422B (de) Verfahren zur herstellung von vindesinmonosulfat
ATA814978A (de) Verfahren zur herstellung von 2,6-methano-3- -benzazocinen
ATA713279A (de) Verfahren zur herstellung von ketonen
DD134954A1 (de) Verfahren zur herstellung von triorganohalogensilanen
DD138903A1 (de) Verfahren zur herstellung von 4-alkylmercapto-2-aryl-5-aryliden-imino-thiazolen
DD135721A1 (de) Verfahren zur herstellung von aminodiphenylaethern
AT366661B (de) Verfahren zur herstellung von cisbicyclooctylaminen
DD136836A1 (de) Verfahren zur herstellung von mercaptogibberellinen
DD135901A1 (de) Verfahren zur herstellung von monothiodiaroylaminen
AT361943B (de) Verfahren zur herstellung von aminoalkyltheo- phyllinen
ATE1527T1 (de) Verfahren zur herstellung von tetramisol.

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee